regard Clinical Packaging Solutions Item Number 830096005, OB01054E - Newborn Kit, containing 2 2...

FDA Device Recall #Z-0411-2022 — Class II — November 4, 2021

Recall Summary

Recall Number Z-0411-2022
Classification Class II — Moderate risk
Date Initiated November 4, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm ROi CPS LLC
Location Republic, MO
Product Type Devices
Quantity 40 kits

Product Description

regard Clinical Packaging Solutions Item Number 830096005, OB01054E - Newborn Kit, containing 2 25GA x .625IN needles.

Reason for Recall

The kit contains a non-sterile needle.

Distribution Pattern

Distribution was made to Missouri. There was no foreign/military/government distribution.

Lot / Code Information

Lot #90074, Exp. 04/17/2023. UDI (01)10194717112938(17)230417(10)90074.

Other Recalls from ROi CPS LLC

Recall # Classification Product Date
Z-1047-2025 Class I regard Item Number: 830106006, LD01114F - Newbo... Dec 26, 2024
Z-3159-2024 Class II regard Clinical Packaging Solutions, HT00376I -... Jul 24, 2024
Z-2685-2024 Class II Regard Kit containing the Microtek decanter Jun 17, 2024
Z-0620-2024 Class I regard Operative LAP, Item Number 800943001; su... Dec 18, 2023
Z-0596-2024 Class I Regard Dressing change kit, Item Number 800026006 Nov 20, 2023

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.